| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 1060 |
| 1 | OLANZAPINE | 162 |
| 2 | PREDNISONE | 162 |
| 3 | ALBUTEROL SULFATE | 147 |
| 4 | LANSOPRAZOLE | 124 |
| 5 | MEPOLIZUMAB | 111 |
| 6 | ALBUTEROL | 108 |
| 7 | ARIPIPRAZOLE | 104 |
| 8 | ARIPIPRAZOLE ORAL | 97 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDETATE CALCIUM DISODIUM | 29 | 0.7250 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 10 | 0.0926 |
| 2 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 3 | AMISULPRIDE | 82 | 0.0137 |
| 4 | CLOZAPINE | 1060 | 0.0085 |
| 5 | SODIUM HYALURONATE | 6 | 0.0075 |
| 6 | CHLORPROMAZINE | 19 | 0.0054 |
| 7 | DIFLORASONE DIACETATE | 1 | 0.0053 |
| 8 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 9 | GOSERELIN | 57 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 1084 |
| 1 | Corticosteroid [EPC] | 322 |
| 2 | Benzodiazepine [EPC] | 202 |
| 3 | Proton Pump Inhibitor [EPC] | 191 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 173 |
| 5 | Interleukin-5 Antagonist [EPC] | 112 |
| 6 | Mood Stabilizer [EPC] | 105 |
| 7 | Vitamin C [EPC] | 101 |
| 8 | Anti-epileptic Agent [EPC] | 96 |
| 9 | Vitamin B12 [EPC] | 96 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 82 | 0.0108 |
| 1 | Osmotic Diuretic [EPC] | 13 | 0.0025 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 46 | 0.0023 |
| 3 | Interleukin-5 Antagonist [EPC] | 112 | 0.0022 |
| 4 | Atypical Antipsychotic [EPC] | 1084 | 0.0021 |
| 5 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0016 |
| 6 | Typical Antipsychotic [EPC] | 40 | 0.0016 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 30 | 0.0016 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 24 | 0.0012 |
| 9 | Rifamycin Antimycobacterial [EPC] | 4 | 0.0012 |